In the North American biotech space, you hear a lot of ‘promise’ from companies and their teams. Lots of ‘we’re going to take this to trial’, and a lot…
Chris Parry
Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a wider market, has announced…
Just a few months since announcing they were merging with Askott Entertainment, a deal that brought casino gaming and daily fantasy sports access to FansUnite’s (FANS.C) sports betting platform,…
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a rough few years for…
When we first talked about Tocvan Ventures (TOC.C) back in June, it was selling for around $0.15 and nobody was really talking about it. In certain markets, hype is…
If you’ve been paying attention over the last few years, you’ve seen a few nice runs for companies engaged in the security/military space. Patriot One (PAT.C) has done nicely…
For the last several years, a lot of stories I’ve written on this site have been about promise. The promise of something better, cheaper, with more upside, with less…
UK-based commodities reporter Pratima Desai appears to have either been a useful idiot or a willing accomplice to a stock price run and subsequent insider sell-off of Canadian smallcap…
Not so long ago, one of our sales guys called Desert Mountain Energy (DME.V) and said, ‘yo desert bros, we like helium, you got helium, let’s work together.’ DME…
CEO Peter Berdusco is throwing all the escape plans possible at his Guyana Goldstrike (GYA.V), as the company continues to capsize after three years of stock price drops and…